Japanese physicians' attitudes toward end-of-life discussion with pediatric patients with cancer

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Saran YoshidaMasashi Kato

Abstract

We explored pediatricians' practices and attitudes concerning end-of-life discussions (EOLds) with pediatric patients with cancer, and identified the determinants of pediatricians' positive attitude toward having EOLds with pediatric patients. A multicenter questionnaire survey was conducted with 127 pediatricians specializing in the treatment of pediatric cancer. Forty-two percent of participants reported that EOLds should be held with the young group of children (6-9 years old), 68% with the middle group (10-15 years old), and 93% with the old group (16-18 years old). Meanwhile, 6, 20, and 35% of participants answered that they "always" or "usually" discussed the incurability of the disease with the young, middle, and old groups, respectively; for the patient's imminent death, the rates were 2, 11, and 24%. Pediatricians' attitude that they "should have" EOLds with the young group was predicted by more clinical experience (odds ratio [OR] 1.077; p = 0.007), more confidence in addressing children's anxiety after EOLd (OR 1.756; p = 0.050), weaker belief in the demand for EOLd (OR 0.456; p = 0.015), weaker belief in the necessity of the EOLd for children to enjoy their time until death (OR, 0.506; p = 0.021), and weaker belief ...Continue Reading

References

Mar 16, 2000·Journal of General Internal Medicine·R B Balaban
May 2, 2001·The Cochrane Database of Systematic Reviews·J T ScottI Watt
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Walter F BaileLorenzo Cohen
Aug 15, 2003·The Cochrane Database of Systematic Reviews·J T ScottI Watt
Sep 17, 2004·The New England Journal of Medicine·Ulrika KreicbergsGunnar Steineck
Sep 24, 2004·Psycho-oncology·Sally-Ann ClarkeChristine Eiser
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Estela A BealeJoann Aaron
Sep 4, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Cynthia J BellVictoria L Champion
Dec 15, 2010·Journal of Pain and Symptom Management·Saran YoshidaYasuo Shima
Jan 26, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey M PeppercornUNKNOWN American Society of Clinical Oncology
Jul 19, 2011·Japanese Journal of Clinical Oncology·Hiroyuki OtaniKeiko Shiraisi
Nov 28, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alisha KassamJoanne Wolfe
Feb 13, 2013·Pediatrics·Julia D LotzMonika Führer
Aug 15, 2013·Journal of Oncology Practice·Leeat GranekPaolo Mazzotta
Jun 7, 2014·Japanese Journal of Clinical Oncology·Saran YoshidaMasashi Kato
Jan 4, 2017·The Journal of Pediatrics·Nobuyuki YotaniHaruo Shintaku

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.